- Home
- BDL vs PSTV Comparison
BDL vs PSTV Comparison
Compare BDL & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- PSTV
- Stock Information
- Founded
- BDL 1959
- PSTV 1996
- Country
- BDL United States
- PSTV United States
- Employees
- BDL N/A
- PSTV N/A
- Industry
- BDL Restaurants
- PSTV Medical/Dental Instruments
- Sector
- BDL Consumer Discretionary
- PSTV Health Care
- Exchange
- BDL Nasdaq
- PSTV Nasdaq
- Market Cap
- BDL 52.7M
- PSTV 61.1M
- IPO Year
- BDL N/A
- PSTV N/A
- Fundamental
- Price
- BDL $31.55
- PSTV $0.52
- Analyst Decision
- BDL
- PSTV Strong Buy
- Analyst Count
- BDL 0
- PSTV 4
- Target Price
- BDL N/A
- PSTV $7.75
- AVG Volume (30 Days)
- BDL 2.1K
- PSTV 8.8M
- Earning Date
- BDL 08-12-2025
- PSTV 10-30-2025
- Dividend Yield
- BDL 1.67%
- PSTV N/A
- EPS Growth
- BDL 41.91
- PSTV N/A
- EPS
- BDL 2.32
- PSTV N/A
- Revenue
- BDL $201,851,000.00
- PSTV $5,258,000.00
- Revenue This Year
- BDL N/A
- PSTV $9.91
- Revenue Next Year
- BDL N/A
- PSTV $1.06
- P/E Ratio
- BDL $14.19
- PSTV N/A
- Revenue Growth
- BDL 8.84
- PSTV N/A
- 52 Week Low
- BDL $22.61
- PSTV $0.16
- 52 Week High
- BDL $35.98
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- BDL 59.25
- PSTV 42.13
- Support Level
- BDL $31.00
- PSTV $0.49
- Resistance Level
- BDL $31.97
- PSTV $0.55
- Average True Range (ATR)
- BDL 0.87
- PSTV 0.05
- MACD
- BDL 0.06
- PSTV -0.01
- Stochastic Oscillator
- BDL 79.53
- PSTV 13.70
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).